ReviewCureus2025
Balancing Surgical Innovation and Risk: A Narrative Review of Emerging Technologies, Regulation, and Global Access.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- TMJ Replacement as a System: Results of an International Surgeon Survey on Design, Fixation, Materials, and Digital Workflow.Craniomaxillofacial trauma & reconstruction · 2026Article
- Neurosurgery Advancements: From Technical Innovation to Patient-Centered Outcomes-A Narrative Review.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surgical innovation has significantly advanced patient care, enabling complex procedures and improving outcomes. However, the integration of new technologies presents challenges related to patient safety, regulatory oversight, cost-effectiveness, and equitable global access. The balance between fostering innovation and ensuring responsible implementation remains a critical issue in modern healthcare. This narrative review explores the evolution of surgical innovation, highlighting key historical advancements, regulatory frameworks, and emerging technologies such as artificial intelligence (AI) in intraoperative decision-making and virtual reality (VR) in surgical education, as illustrative examples of transformative technologies. It discusses financial and ethical considerations, including the impact of frugal innovation in low-resource settings and the role of tiered regulatory approaches in mitigating risk. Effective adoption of surgical innovations requires adaptable regulatory models, continuous training programmes, and a multi-stakeholder approach that includes policymakers, healthcare providers, and industry leaders. Addressing financial constraints and ethical dilemmas is essential to ensure that novel surgical technologies are accessible, safe, and sustainable. Future efforts should prioritise dynamic regulatory mechanisms, equitable innovation dissemination, and interdisciplinary collaboration to maximise the benefits of surgical advancements while minimising risks. A structured approach, balancing technological progress, patient safety, and global equity, is crucial to shaping the future of surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.